KAIST
|
Newsletter | Vol.32.2025.10.31 |
|
| KAIST Exports Global License for New Drug Candidate for Intractable Epilepsy Worth 750 Billion KRW |
| Campus/People | ||
|
||
|
||
|
|
| KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea T.042-350-2114 F.042-350-2210(2220) Copyright(C) 2020, Korea Advanced Institute of Science and Technology, All Rights Reserved. UNSUBSCRIBE |